Sanofi | SNY - Activos Circulantes





Activos Circulantes Cambio Fecha
AbbVie USD 33.67B 140M 2026-06
Amgen USD 34.96B 3.49B 2026-06
AstraZeneca USD 31.45B 3.48B 2026-09
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Canopy Growth CAD 506.36M 23.1M 2026-06
Corcept Therapeutics USD 439.68M 13.64M 2026-06
Drreddys Laboratories INR 297.58B 4.4B 2026-09
Eli Lilly USD 65.26B 591M 2026-09
Genmab DKK 2.8B 228M 2026-06
GlaxoSmithKline GBP 17.9B 336M 2026-09
Glaxosmithkline GBP 17.9B 134M 2026-09
J&J USD 56.35B 3.42B 2026-09
Lakefront Biotherapeutics EUR 2.31B 751.38M 2026-06
Merck USD 36.68B 1.66B 2026-06
Novartis USD 28.75B 1.4B 2026-09
Novartis USD 28.75B 2.14B 2026-09
Pacira USD 615.21M 100.25M 2026-06
Perrigo USD 2.45B 260.7M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Phibro Animal Health USD 935.51M 41.44M 2026-06
Prestige Brands USD 496.81M 65.33M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 33.21B 1.68B 2026-09
Sanofi EUR 31.52B 1.36B 2026-06
Supernus Pharmaceuticals USD 711.21M 12.28M 2026-09
UCB EUR 6.05B 733M 2025-12
Zoetis USD 6.36B 118M 2026-06